Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia
Jean‐Emmanuel Bibault(Inserm), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Shéhérazade Sebda, Aline Renneville(Université Paris-Sud), Nathalie Hélevaut(Inserm), Céline Rodriguez(Eramet (France)), Olivier Nibourel(Inserm), Sabine Quief(Institut pour la Recherche sur le Cancer de Lille), Sylvie Castaigné(Hôpital André Mignot), Philippe Rousselot(Hôpital André Mignot), Hervé Dombret(University of London Institute in Paris), Martin Figeac, Bérengère Gruson(Centre Hospitalier Universitaire Amiens-Picardie)
Cited by 57
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k